India has lifted an export ban on hydroxychloroquine, the anti-malarial drug touted by US President Donald Trump as a potential “game changer” in the fight against the COVID-19
Looking at the records of 96,000 patients across hundreds of hospitals, researchers found that administering the drugs actually increased the risk of dying
President Donald Trump on Monday made the surprise announcement that he is taking hydroxychloroquine, an anti-malaria drug that his own government experts say is not suitable for fighting the novel coronavirus.